EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effects of glucagon‐like peptide‐1 analogs on prolactin levels: A secondary analysis of a randomized, double‐blind, placebo‐controlled crossover trial

Vera Reber iD, Cyrill Denis Mueller iD, Sophia Lengsfeld, Leila Probst, Laura Werlen iD, Richard Allen, Yara Emara, Cemile Bathelt, Bettina Winzeler iD

Journal of Neuroendocrinology · 2026-11 · 38 (11)

DOI: 10.1111/jne.70308 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 05.11.2026. Verfasst von Vera Reber und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Prolactin, Glucagon-Like Peptides, Recombinant Fusion Proteins, Immunoglobulin Fc Fragments. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Gottfired & Julia Bangerter-Rhyner Stiftung, Goldschmidt-Jacobson Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prolactin (PRL) is involved in the modulation of sexual function. Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have been proposed to modulate reward‐related processes beyond their effects on appetite, including sexual desire. In our previously published randomized parent trial of dulaglutide and sexual desire, we hypothesized that any potential effect on sexual desire could involve changes in PRL concentrations. Predefined secondary analysis of a single‐center randomized, double blind, placebo‐controlled, crossover trial involving 24 healthy eugonad men of normal weight (BMI 18.5–25 kg/m 2 or BMI 25.1–30 kg/m 2 and waist circumference

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProlactinGlucagon-Like PeptidesRecombinant Fusion ProteinsImmunoglobulin Fc FragmentsGlucagon-Like Peptide 1HumansMaleDouble-Blind MethodCross-Over StudiesAdultYoung Adult

Stichwörter der Autor:innen

GLP‐1GLP‐1 analogsneuroendocrinologyprolactinreward system

Substanzen

ProlactindulaglutideGlucagon-Like PeptidesRecombinant Fusion ProteinsImmunoglobulin Fc FragmentsGlucagon-Like Peptide 1

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland.
  • Department of Clinical Research, University of Basel, Basel, Switzerland.
  • Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.

ORCID-Profile: Vera Reber, Cyrill Denis Mueller, Laura Werlen, Bettina Winzeler

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Gottfired & Julia Bangerter-Rhyner Stiftung
  • Goldschmidt-Jacobson Foundation
  • Department of Internal Medicine of the University Hospital of Basel
  • Schweizerische Akademie der Medizinischen Wissenschaften

Zitieren

APA

Reber, V., Mueller, C. D., Lengsfeld, S., Probst, L., Werlen, L., Allen, R., Emara, Y., Bathelt, C., & Winzeler, B. (2026). Effects of glucagon‐like peptide‐1 analogs on prolactin levels: A secondary analysis of a randomized, double‐blind, placebo‐controlled crossover trial. Journal of Neuroendocrinology, 38(11). https://doi.org/10.1111/jne.70308

Vancouver

Reber V, Mueller CD, Lengsfeld S, Probst L, Werlen L, Allen R, et al. Effects of glucagon‐like peptide‐1 analogs on prolactin levels: A secondary analysis of a randomized, double‐blind, placebo‐controlled crossover trial. Journal of Neuroendocrinology. 2026;38(11). doi:10.1111/jne.70308

BibTeX
@article{Reber2026,
  author = {Reber, Vera and Mueller, Cyrill Denis and Lengsfeld, Sophia and Probst, Leila and Werlen, Laura and Allen, Richard and Emara, Yara and Bathelt, Cemile and Winzeler, Bettina},
  title = {Effects of glucagon‐like peptide‐1 analogs on prolactin levels: A secondary analysis of a randomized, double‐blind, placebo‐controlled crossover trial},
  journal = {Journal of Neuroendocrinology},
  year = {2026},
  volume = {38},
  number = {11},
  doi = {10.1111/jne.70308}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche